Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor
- 24 July 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 401 (1) , 17-25
- https://doi.org/10.1016/s0014-2999(00)00439-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptorEuropean Journal of Pharmacology, 1999
- Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsinJournal of Molecular Biology, 1998
- Mutagenesis and Modeling of the Neurotensin Receptor NTR1: IDENTIFICATION OF RESIDUES THAT ARE CRITICAL FOR BINDING SR 48692, A NONPEPTIDE NEUROTENSIN ANTAGONISTPublished by Elsevier ,1998
- A New Approach to Docking in the β2-Adrenergic Receptor That Exploits the Domain Structure of G-Protein-Coupled ReceptorsJournal of Medicinal Chemistry, 1997
- Gly166in the NK1receptor regulates tachykinin selectivity and receptor conformation1FEBS Letters, 1997
- A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1Journal of Biological Chemistry, 1997
- Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte SubpopulationsEuropean Journal of Biochemistry, 1995
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Molecular cloning of a human cannabinoid receptor which is also expressed in testisBiochemical Journal, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990